Equities

Win-Partners Co Ltd

3183:TYO

Win-Partners Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,263.00
  • Today's Change-5.00 / -0.39%
  • Shares traded7.50k
  • 1 Year change+3.02%
  • Beta0.6025
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Win-Partners Co Ltd had net income fall -10.33% from 2.05bn to 1.84bn despite a 8.76% increase in revenues from 70.85bn to 77.06bn. An increase in the selling, general and administrative costs as a percentage of sales from 8.74% to 8.96% was a component in the falling net income despite rising revenues.
Gross margin12.28%
Net profit margin2.45%
Operating margin3.60%
Return on assets4.60%
Return on equity8.79%
Return on investment8.31%
More ▼

Cash flow in JPYView more

In 2024, Win-Partners Co Ltd increased its cash reserves by 11.71%, or 1.38bn. The company earned 3.04bn from its operations for a Cash Flow Margin of 3.95%. In addition the company used 219.47m on investing activities and also paid 1.45bn in financing cash flows.
Cash flow per share76.48
Price/Cash flow per share17.71
Book value per share798.13
Tangible book value per share784.61
More ▼

Balance sheet in JPYView more

Win-Partners Co Ltd uses little or no debt in its capital structure.
Current ratio1.83
Quick ratio1.68
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in JPY

Year on year, growth in dividends per share increased 38.89% while earnings per share excluding extraordinary items fell by -10.60%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is in-line with the industry average relative to its peers, while earnings per share growth is below the industry average.
Div yield(5 year avg)3.57%
Div growth rate (5 year)9.34%
Payout ratio (TTM)72.16%
EPS growth(5 years)-6.88
EPS (TTM) vs
TTM 1 year ago
-1.93
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.